Last reviewed · How we verify

NCT06903247

Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

ENROLLING BY INVITATION Last updated 18 November 2025
What this trial tests

trial testing Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation. in Neurosonographic Findings of Vitamin D Deficiency in 100 participants. Enrolling by invitation.

Timeline
15 March 2025
Primary endpoint
30 June 2025
30 November 2025

Quick facts

Lead sponsorSanliurfa Education and Research Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment100
Start date15 March 2025
Primary completion30 June 2025
Estimated completion30 November 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sanliurfa Education and Research Hospital

Who can join

Adults 18 to 50, female only, with Neurosonographic Findings of Vitamin D Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sanliurfa Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06903247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing